Answers are grounded in this paper and cite their sources.
These findings suggest that systemic miRNAs have potential use as novel breast cancer biomarkers and may prove useful in clinical management during the perioperative period.
No takes yet. Share an insight, caveat, or question.
Heneghan et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: